Beyond PARP Inhibitors: Agents in Pipelines Target DNA Repair Mechanisms.Published in:JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 15, p. 1110, doi. 10.1093/jnci/djq294By:Maxmen, AmyPublication type:Article
PARP inhibitors blaze a trail in difficult-to-treat cancers.Published in:Nature Biotechnology, 2009, v. 27, n. 9, p. 784, doi. 10.1038/nbt0909-784By:Kling, JimPublication type:Article
A walk through the Valley of Death.Published in:Nature Biotechnology, 2008, v. 26, n. 7, p. 833, doi. 10.1038/nbt0708-833By:Paul, MariPublication type:Article